Lexaria Bioscience Corp generated $706K in revenue in fiscal year 2025. This represents an increase of 52.0% from the prior fiscal year. Over the trailing 12 months, Q4 FY2025 through Q3 FY2026, the same line adds up to $194K in revenue. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Lexaria Bioscience Corp has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
LEXX Revenue by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
TTM is the trailing twelve months, Q4 FY2025 through Q3 FY2026, summed from the four most recent quarterly filings.
LEXX Revenue by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What revenue means
Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.
More Lexaria Bioscience Corp financials
Frequently Asked Questions
What was Lexaria Bioscience Corp's revenue in fiscal year 2025?
Lexaria Bioscience Corp generated $706K in revenue in fiscal year 2025.
How fast is Lexaria Bioscience Corp's revenue growing?
Lexaria Bioscience Corp (LEXX) revenue rose by 52.0% year over year, from $464K to $706K in fiscal year 2025.
What is Lexaria Bioscience Corp's revenue over the last twelve months?
Lexaria Bioscience Corp (LEXX) reported $194K in revenue over the trailing 12 months, Q4 FY2025 through Q3 FY2026, summed from the four most recent quarterly filings.
What was Lexaria Bioscience Corp's revenue in the most recent quarter?
Lexaria Bioscience Corp (LEXX) reported $0 in revenue in Q3 2026. This represents a decrease of 100.0% from the same quarter a year earlier.
What does revenue mean on a financial statement?
Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what Lexaria Bioscience Corp (LEXX) reported on that line in every period on record.